The first syntheses of fluorine-18 labeled inhibitors of GABA reuptake [(R,S)-
Introduction
Gamma aminobutyric acid (GABA) is an inhibitory amino acid neurotransmitter involved in the control of neuronal activity in the brain (Enna, 1980; Krogsgaard-Larsen et al., 1987) . Dysfunctions of the GABA system have been implicated in a wide variety of neurological disorders, and are of particular interest in studies of epilepsy and other seizure disorders. In vivo approaches to. the study of the GABA system in man using positron emission tomography (PET) have centered on the preparation and application of radiolabeled ligands known to bind to the GABA/benzodiazepine receptor complex (Maziere et al., 1980 (Maziere et al., , 1984 Frost et al., 1986 ).
An alternative approach to the study of the role of degeneration of the GABA neurotransmitter pathway in disease would be development of in oivo markers of the presynaptic GABA-ergic neurons. Reasonable approaches are the development of radiolabeled synthetic precursors to GABA formation; radiolabeled inhibitors of the enzymes involved in GABA production (e.g. glutamic acid decarboxylase, GAD); or radiolabeled inhibitors of the presynaptic GABA reuptake system. This last option is particularly appealing due to the interest in developing drugs *All correspondence should be addressed to: Michael R.
Kilbourn, Ph.D., Cyclotron/PET Facility, 3480 Kresge III, University of Michigan, Ann Arbor, MI 48109, U.S.A.
that block this process for use in treatment of epilepsy (Krogsgaard-Larsen et al., 1987) . The mechanisms of GABA uptake are not well understood, and there is relatively little data regarding in vivo pharmacokinetics and specificity of GABA uptake inhibitors. We describe here the first synthesis of novel 18F labeled GABA uptake inhibitors (Fig. 1: Pavia, 1988; Taylor and Vartanian, 1989) as potential radioligands for studying the GABA system by in vivo methods (ex vivo tissue counting, in vivo autoradiography, and PET).
Materials

Experimental
The following were obtained from Aldrich Chemical Co. and used without further purification: terephthaldehyde, diethylaminosulfur trifluoride (DAST), 4-bromobenzotrifluoride, Kryptofix 2.2.2, lithium aluminum hydride (1 M in diethyl ether). The quaternary ammonium resin was prepared as previously described (Mulholland et al. 1989b) . High specific activity (50,000 Ci/mmol) ['8F]fluoride ion was produced by proton irradiation of ['80] water held in an all silver cyclotron target as previously described (Mulholland et al., 1989a) . Preparations of 4-["Flfluorobenzhydryl chloride (11) (Haka et al., 1989) and 4-["Flfluoro-4'-fluorobenzhydryl chloride (12) (Haka and Kilbourn, 1990) were according to literature methods. labeled inhibitors of GABA reuptake.
Methods
Melting points were determined on a ThomasHoover capillary melting point apparatus and are uncorrected.
NMR spectra were recorded with a Varian EM-390 spectrometer using TMS as internal reference.
Infrared spectra were recorded with a Nicolet XS-20 FT-IR spectrometer using KBr plates. Thin layer chromatography was done using plasticbacked silica gel plates (Merck) and the following systems: System A, silica gel, 5/2 pentane/diethyl ether; System B, silica gel, 7/3 hexane/ethylacetate; System C, 7/2.5/0.5 toluene/isopropanol/acetic acid. HPLC was done using a Phenomenex Cl8 10~ 0.45 x 10 cm column fitted with U.V. (263 nm) and radioactivity detectors, and a mobile phase of 60/40/3 acetonitrile/0.065 M aqueous ammonium acetate/ tetrahydrofuran (flow rate 0.5 mL/min). All radiochemical yields are corrected for decay of '"F (t,,* = I IO min).
4-(D@oromethyl)benzaIdehyde (5).
Terephthaldehyde (4: 38 g, 0.28 mol) was dissolved in dichloromethane (350mL), a nitrogen atmosphere introduced, and the mixture cooled to -10°C. A solution of DAST (38 g, 0.24mol) in dichloromethane (50 mL) was added dropwise over 1 h. The reaction was stirred for 4 days at room temperature, quenched very carefully by slow (30 min) addition of water (25 mL), and neutralized with saturated aqueous NaHCO,.
The aqueous layer was repeatedly extracted with CH,Cl,, and the extracts dried (MgSO,). filtered through silica and evaporated in L'acuo at temperature < lO"C. The remaining oil (36 g) was distilled (113-l 15 'C, 20 torr) to give 19.9 g (54% yield) of the desired aldehyde 5, which was used in the next step without further purification. 'H-NMR (CDCI,) S 9.8 (bs, IH, CHO), 7.65-7.35 (dd, 4H. ArH), 6.68 (t, lH, J = 55.9 Hz, CHF& 6. 4 Bromobenzotrifluoride (2.25 g, IO mmol) was added dropwise to a mixture of magnesium metal (0.24g, IOmmol) in diethyl ether (30 mL). The reaction was initiated (manual crushing of Mg, addition of iodine crystal) and the 4-bromobenzotrifluoride added at a rate sufficient to maintain reflux. When the addition was complete, the reaction was refluxed for an additional 45 min and then cooled to 0 C. Approximately one-fifth of this Grignard reagent was then added to a solution of 5 (0.31 g, 2 mmol) dissolved in cold ether (2 mL, O'C). [
The benzhydro16 (0.6 g, 2 mmol) was dissolved in acetone (30 mL) and cooled to 0°C. Jones reagent (CrO, / H, SO, / Hz 0) was added dropwise until an orange color persisted. The reaction was stirred an additional 5 min then quenched by addition of methanol.
The product was poured into ether. the solid removed, and the organic layer evaporated 8. The benzophenone 7 (3.0 g. IO mmol) was suspended in Ccl, (40 mL) and to this added anhydrous K,CO, (6.9 g, 50 mmol) and then Br, (I .76 g, 11 mmol). The reaction mixture was placed under an atmosphere of N, and illuminated with a 275W sunlamp which raised the temperature to 45°C. After 24 h additional Br, (I .76 g, IO mmol) was added and the reaction continued for a total of 60 h, at which time TLC (silica, 5% EtOAC/hexane) showed complete conversion. The reaction mixture was cooled, diluted with CH,Cl,, and then washed with saturated aqueous soldium silfite and sodium chloride solutions. The organic layer was dried (MgSO,) and evaporated to give a solid which was dissolved 8 (2 mg) was added, and the solution heated at 150°C for 20 min. The mixture was cooled, diluted with water, and passed through a C-18 Sep-Pak. The solid phase was washed with water (5 mL) then the product eluted with diethylether (2 mL). Yields ranged from 20-75% with an average of 50%. The product 9 was used in the next step without further purification.
TLC System A) R, = 0.57.
(R,S)-['*F&is-(4-Trifluoromethyl)benzhydrol 10.
To a solution of ketone 9 (lOOpCi-5 mCi) in diethyl ether was added LAH (200 uL of 1M in THF) and the solution allowed to stand at 25°C for 5 min. Excess LAH was carefully quenched with water, 2 N H, SO, added, and the mixture passed through a C-18 Sep-Pak. The product was eluted with diethyl ether (2 mL) and then ether dried (Na*SO,) to yield a solution of the desired alcohol 10 (yields 85-95%). This was not further purified but used in the next step in the sequence. TLC (System A) R, = 0.2. To the residue of chloride 13 was added ethyl N-(2-hydroxyethyl)-piperidine-3-carboxylate (10 mg), and the mixture heated at 155°C for 25 min. The resultant brown oil was dissolved in methanol (100 FL), diluted with water (2 mL) and extracted with diethyl ether. The ether layers were combined and dried (Na,SO,) and the ether evaporated (N, flow). The residue was dissolved in dichloromethane and passed through a short column of silica gel to yield the desired crude product 16. Yield 33%; TLC (System B) Rf = 0.43.
(R,S)-Ethyl 1-[2-J(4-['8F]fluorophenyl)phenyl)methox)lethyl]-piperidine-3-carboxylate (14)
. This condensation was performed as per synthesis of 16, using the chloride 11; yield 49%; TLC (System B) R,= 0.375.
(R,S)-Ethyl-l-[2-(4-['nF]fluorophenyl)(4-Jluorophenyl)methoxyethyl]piperidine-3-carboxylate (15).
This ester was prepared utilizing chloride 12 as per the synthesis of 14: yield 31%. TLC (System B) R, = 0.28; (System C)R, = 0.68.
(R,S)-l-[2-{(4-['8F]Tripuoromethyl)phenylj {(4-trijIuoromethyl)phenyl~methoxyethyl]-piperidine-3-carboxylic acid (3).
The crude ethyl ester 16 was dissolved in 3 drops 6 N H,S04 and heated (100°C) for 30 min. The acid solution was diluted with 6 mL of 20 mM K,HPO, buffer (pH 6.5) and extracted with two 2 mL portions of 4/l chloroform/isopropanol. The organic layers were combined, dried, and evaporated in vacua. Yield 83%, radiochemical purity 95%; TLC (System C) R, = 0.42; HPLC R, = 8.88 min.
(
R,S)-I-[2-((4-['8F]Fluorophenyl)phenyl}methoxy-ethyl]-piperidine-3-carboxylic acid (1).
Hydrolysis of the ethyl ester 14 was done as per the synthesis of 3. Yield 90%, radiochemical purity 97%; TLC (System B) Rf = 0.05, (System C) RI= 0.35; HPLC R, = 6.83 min.
R,S)-l-{2-(4-['8F]Fluorophenyl)(4-fluorophenyl)-methoxyethyljpiperidine-3-carboxylic acid (2).
Hydrolysis of the ester 15 was done as per synthesis of 3. Yield 85%, radiochemical purity 96%; TLC (System B) Rf = 0.05: (System C) Rf = 0.40; HPLC R, = 7.12 min.
Results and Discussion
Preparation of radiolabeled inhibitors of the high affinity GABA uptake system would form a new and potentially powerful method for examining the distribution and function of this neurotransmitter system in vivo. GABA uptake sites show a heterogeneous distribution in primate brain, with a more than 4-fold difference between areas of low concentration (pons, deep cerebellar nuclei) and those of high concentration (amygdala, hypothalamus, globus pallidus) (Enna, 1981 and Langstrom, 1989) but suffers the same in vivo limitation). Preparation of esters of such acids provides prodrugs which do pass through the BBB and are hydrolyzed in the brain to the active parent drugs (Frey et al., 1979; Falch et al., 1978) . Application of prodrugs to PET imaging, although interesting, may be too complicated for successful analysis of in vivo pharmacokinetics.
The placement of small alkyl groups on the nitrogen in guvacine or nipecotic acid has resulted in compounds which are less active than the parent amino acids, but surprisingly the attachment of large lipophilic groups, such as diarylbutenyl (Ah et al., 1985; Braestrup et al., 1990; Sonnewald, 1987) or diarylmethoxyethyl groups, (Pavia, 1988; Falch and Krogsgaard-Larsen, 1989 ), provides compounds which are actually more active as GABA inhibitors (IC,, values of 67-30 nM) than the parent amino acids, and do show potent in vivo activity after systemic administration.
One such compound, NO 328 ((R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-lyllnipecotic acid), has been recently prepared in tritiated form and its in vitro and in vivo behavior examined in some detail (Braestrup et al., 1990) .
Their results (Kn = 18 nM, and regional variation in binding to brain synaptosomes) are encouraging for further development of radiohgands for GABA uptake sites. As we have recently developed general routes to '*F labeled diarylmethanols (4-['*F]fluorobenzhydrol, Haka et al., 1989; 4-(['*F] fluorophenyl) (2-thienyl)methanol, Kilbourn, 1989; 4-["Flfluoro-4'-fluorobenzhydrol, Haka and Kilbourn, 1990) , the application of such precursors to synthesis of '"F labeled derivatives of these cyclic amino acids appeared promising. A large number of substituted diphenylmethoxyethyl derivatives of nipecotic acid and guvacine have been recently reported (Pavia, 1988) and we chose to prepare fluoroaryl (1,2) and trifluoromethyl (3) substituted diarylmethoxyethyl derivatives to test the feasibility of our synthetic approach. The reported IC,, for GABA uptake for compound 3 (as the R(-) stereoisomer) is 200 nM (Taylor and Vartanian, 1989) ; data for the other two compounds have not been reported. The K, values, which for NO 328 (18 nM) is significantly lower than the IC,, for GABA uptake (67 nM), have also not yet been reported. Synthesis of the target molecules was broken down into two parts, the preparation of the appropriately labeled benzhydryl chlorides (11,12,13), bromide to give the benzhydrol 6 in 80% yield. The alcohol was oxidized to the ketone (7, 74% yield) using Jones reagent under standard conditions. Bromination of the difluoromethyl group was performed using bromine in Ccl, under photolytic conditions (90% yield), with solid potassium carbonate added to consume HBr formed in the reaction. This bromodifluoromethyl group was then converted to a "F labeled trifluoromethyl group by a simple reaction with no-carrier-added ["Fjfluoride ion (as salt with tetrabutylammonium, K+/Kryptofix, or quaternary ammonium resin (Mulholland et al., 1989b) counterion) in 50% yield (average; 25 min reaction time). The ease of this synthesis of a ["Fltrifluoromethyl group was surprising since previous attempts at r8F-for-"F (Ido et al., 1987) or "F-for-Cl (Angelini et al., 1986) substitutions required high temperature and/or Lewis acid catalysts, and products were obtained in only moderate yields. The ketone 9 was then reduced (10: LAH; 90% yield) and chlorinated (PCI, in CH,CI, or neat SOCI,; 955100% yield) to give the required benzylic chloride 13. The benzhydryl chlorides 11,12,13 were reacted with (N-2-hydroxyethyl)nipecotic acid ethyl ester (Fig. 3) to yield the intermediate ethers 14,15,16 in 3349% yields. The products were separated from unreacted benzylic chlorides by extraction of the piperidine derivatives into dilute aqueous acid, and from excess N-hydroxynipecotic acid ester by a short column of silica gel. Finally, the ester groups were hydrolyzed under acidic conditions to yield the free amino acids 1,2,3. Products were obtained in high radiochemical purities (> 95% by TLC and/or HPLC) but all contained trace amounts of chemical impurities.
Small amounts of chemically pure products were obtained after injection of portions of the crude products on the analytical HPLC column. All of the final product acids 1,2 and 3 have been obtained as racemic mixtures (mixtures of isomers at the carboxylic acid position) and compound 1 as also a mixture of isomers at the benzylic position.
In this work we have demonstrated the feasibility of preparing 0. l-l .O mCi amounts of "F labeled derivatives of compounds known to be systemically active as GABA uptake inhibitors. Overall radiochemical yields (5 steps from resolubilized ["Flfluoride ion) ranged from 17-28% (corrected, 150 min synthesis The bis(trifluoromethy1) substituted derivative, 3, has also been obtained in nocarrier-added form, but it requires a separation from small amounts of the compound bearing the original bromodifluoromethyl group; without this separation, the effective specific activity should be more properly described as lower (about 1 Ci/mmol) as the chemical contaminant is likely to be biologically active. These specific activities have been sufficient to begin in viuo testing of the compounds in small animals. The effect of stereochemistry at the benzylic position in 1 is unknown, but the R( -) isomer of nipecotic acid and its derivatives are more potent inhibitors of GABA uptake (Pavia, 1988; Taylor and Vartanian, 1989) . Syntheses of the R( -) isomers (carboxylic acid position) should provide better radiotracers, and are currently underway in our laboratories, as is the preparation of the corresponding guvacine derivatives(e.g. I-{2-{bis(trifluoromethyl)phenyl}methoxy}-ethyl)-1,2,5,6-tetrahydro-3-pyridine carboxylic acid, (X-966: (Pavia, 1988; Brahce et al., 1989) and thienylsubstituted derivatives (Kilbourn, 1989) . Preliminary in riuo studies of regional mouse brain distribution of 1 have been encouraging, with a cortex/striatum ratio (% injected dose per gram) of 1.44 + 0.36 at 1 h after injection; this compares favorably with the ratio of 1.53 for spec$c binding of ['HINO 328 to rat brain synaptosomes determined in aitro (Braestrup et al., 1990) . The availability of radiolabeled hgands will allow examination of in cit'o characteristics of this class of compounds (brain extraction; regional distribution and specificity of radiotracer binding in brain; kinetics of radiotracer accumulation and washout from brain; pharmacological specificity of binding; neuronal vs glial specificity).
